Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03956381
Other study ID # CSP2018-03
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 24, 2019
Est. completion date July 31, 2021

Study information

Verified date September 2021
Source Corin
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The primary objective of this study is to determine the accuracy of the Optimized Positioning System (OPS™) planning and delivery tools using different types of surgical approaches.


Description:

Total Hip Replacement (THR) is the gold standard for treatment of severe arthritis of the hip as it relieves pain, restores function of the joint and improves quality of life for patients. The restoration of hip mechanics can be influenced by the selected femoral stem design and also by choices made by the surgeon during the surgical implantation. The combination of femoral neck resection level and angle are key factors, particularly in cementless hip arthroplasty, in determining post-operative leg length and femoral anteversion. Historically, an estimation of prosthesis sizing and positioning has been made via a process of manual or digital templating either pre or intraoperatively using images of the implants positioned over the standard AP and lateral view hip x-rays taken in advance of surgery with generic instruments used during the surgery to execute the femoral head resection at the planned level. This process has a number of limitations. The OPS™ system utilizes detailed pre-operative imaging including a CT scan to generate a plan for the femoral neck resection level and angulation based on the anatomy of the individual patient. Following validation of this plan by the operating clinician, a patient specific femoral guide instrument is generated to help facilitate the reliable delivery of the planned resection intraoperatively. The purpose of this study will be to evaluate the use of the patient-specific femoral instrument in the hands of two surgeons using different prosthesis combinations and surgical approaches. A total number of 40 participants will be enrolled. Participants in this study will return for a single post-operative visit at 6 weeks to have X-rays taken and to enable any post-operative study hip related complications to be recorded. Once this has been completed, participants will be routinely followed-up by their orthopaedic surgeon as required in accordance with standard clinical practice.


Recruitment information / eligibility

Status Completed
Enrollment 55
Est. completion date July 31, 2021
Est. primary completion date June 15, 2021
Accepts healthy volunteers No
Gender All
Age group 21 Years to 85 Years
Eligibility Inclusion Criteria: 1. Patients who understand the conditions of the study and are willing to return to the clinical site at 6 weeks post-operatively. 2. Patients of either gender who are between 21-85 years inclusive. 3. Patients with a diagnosis of osteoarthritis, rheumatoid arthritis or osteonecrosis and are considered by the Investigator to be clinically and medically suitable to undergo a primary total hip replacement 4. Patients who meet the indications and none of the contraindications listed in the Instructions for Use (IFU) supplied by the manufacturer for the femoral stem and acetabular cup to be implanted. 5. Patients who meet the indications and none of the contraindications listed in the Instructions for Use (IFU) supplied by the manufacturer for OPS™ Femoral Plan and OPS™ Femoral Patient Specific Instruments. Exclusion Criteria: 1. Patients who are unable to provide informed consent. 2. Patients who are unable to comply with all the required study procedures. 3. Patients whose insurance will not cover the cost of the pre-operative CT and functional x-ray imaging required for use of the OPS system. 4. Patients who are currently involved in any personal injury litigation, medical-legal or worker's compensations claims.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Primary Total Hip Replacement with Trinity cup and TriFit TS stem via posterolateral surgical approach.
The participant will undergo surgery using the hip prostheses and surgical approach used by their surgeon Investigator. A patient specific femoral guide, generated by the OPS™ plan preoperatively, will be used during the surgical step of femoral neck resection. These are not study specific procedures as the OPS™ system is already in use by the surgeon Investigator in their standard of practice.
Primary Total Hip Replacement with Trinity cup and MetaFix stem via direct anterior surgical approach
The participant will undergo surgery using the hip prostheses and surgical approach used by their surgeon Investigator. A patient specific femoral guide, generated by the OPS™ plan preoperatively, will be used during the surgical step of femoral neck resection. These are not study specific procedures as the OPS™ system is already in use by the surgeon Investigator in their standard of practice.

Locations

Country Name City State
United States Colorado Joint Replacement Denver Colorado

Sponsors (1)

Lead Sponsor Collaborator
Corin

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Accuracy of the final osteotomy level compared to the selected OPS™ plan preopertively. Accuracy of the final osteotomy level compared to the selected OPS™ plan (+ or - 3mm). Two standard of care post-operative x-rays taken at 6 weeks will be used to evaluate the positioning of the total hip prosthesis from the resultant level of resection of the femoral neck. This parameter will be measured in mm. 6 weeks post-op (+/- 2 weeks)
Secondary Comparison of the femoral stem size implanted compared to the selected OPS™ Plan preoperatively (± 1 size) The femoral stem size used during the operation will be compared to the selected one by the OPS™ Plan. This parameter will be measured in units. Immediate postoperative
Secondary Comparison of the acetabular cup size implanted compared to the selected OPS™ Plan preoperatively. The acetabular cup size used during the operation will be compared to the selected one by the OPS™ Plan. This parameter will be measured in mm. Immediate postoperative
Secondary Comparison of the femoral head size implanted compared to the selected OPS™ Plan preoperatively. The femoral head size used during the operation will be compared to the selected one by the OPS™ Plan. This parameter will be measured in mm. Immediate postoperative
Secondary Measurement of any change in Leg length/ femoral head height compared to the preoperative OPS™ Plan (± 5mm). The postoperative Leg length / femoral head height will be measured in mm and compared to the preoperative value. 6 weeks post-op (+/- 2 weeks)
Secondary Comparison of the acetabular cup orientation to the selected OPS™ Plan. The planned versus achieved acetabular cup orientation will be measured using 2D/3D registration software, in degrees. 6 weeks post-op (+/- 2 weeks)
See also
  Status Clinical Trial Phase
Recruiting NCT03968939 - Total Joint Arthroplasty and Sleep Phase 4
Terminated NCT04036071 - Clinical Observation Study of the Hydroxylapatite-coated SLPLUS™MIA Hip Shaft
Completed NCT04209426 - Retrospective Observational Cohort Study of SYMBOL CUP DM 2
Enrolling by invitation NCT05313321 - Survival of the Insignia Stem in Total Hip Arthroplasty
Terminated NCT04121585 - Clinical Observation Study of the Hydroxylapatite-coated SL-PLUS™ Hip Shaft
Completed NCT03690037 - Investigating the Effect of Intravenous and Oral Tranexamic Acid on Blood Loss After Primary Hip and Knee Arthroplasty Phase 4
Completed NCT04209374 - Retrospective Observational Cohort Study of SYMBOL CUP DM 1
Completed NCT04122157 - Prospective Single-center Long-term Observation of the SL-PLUS® MIA Stem
Completed NCT04085640 - Obturator Nerve Block in Total Hip Arthrosplasty N/A
Recruiting NCT04319952 - OPS™ With Direct Anterior Approach (DAA)
Completed NCT05072704 - Opioid Free Anesthesia in Total Hip Arthroplasty Phase 3
Completed NCT03973320 - Outcomes After Hypotensive Neuraxial Anesthesia in Total Hip Arthroplasty
Recruiting NCT01495546 - Total Hip Arthroplasty (THA): Early Load Versus Load Late N/A
Terminated NCT02933671 - Suprainguinal Fascia Iliaca (SIFI) Block Improves Analgesia Following Total Hip Arthroplasty Phase 4